Neuromodulation tech developer Avivomed raises $32 million, names new CEO
Avivomed Inc., a Minneapolis-based medical device company, announced a $32 million Series A round of financing on Thursday.
The company said in a statement a "world-class syndicate of medical device investors" were involved in the round that will allow the company to develop neuromodulation technology that will treat patients suffering from chronic diseases.
Aviviomed also announced it has hired Steve Masson as president and CEO. Masson has 40 years of experience in the medical device business…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Carter Jones Source Type: news